Jaguar Health (JAGX) Operating Income (2014 - 2026)
Jaguar Health (JAGX) reported Operating Income of $10.2 million for Q1 2026, up 208.08% year-over-year from $3.3 million in Q1 2025, and up 147.93% quarter-over-quarter from -$21.2 million in Q4 2025.
Jaguar Health (JAGX) Operating Income (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Operating Income data on file, last reported at $10.2 million in Q1 2026.
- Operating Income for Q1 2026 came in at $10.2 million, up 208.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.3 million (up 17.89% YoY), and the FY2025 annual result was -$45.9 million, down 48.9% from the prior year.
- Operating Income improved to $10.2 million in Q1 2026 per JAGX's latest filing, from -$21.2 million in the prior quarter.
- Over five years, Operating Income peaked at $10.2 million in Q1 2026 and troughed at -$21.2 million in Q4 2025.
- A 5-year average of -$8.0 million and a median of -$8.1 million in 2023 frame the typical range for Operating Income.
- The sharpest annual moves came in 2025 and 2026: Operating Income plunged 160.41% in 2025, then soared 208.08% in 2026.
- A 5-year view of Operating Income shows it stood at -$6.3 million in 2022, then slipped by 20.22% to -$7.6 million in 2023, then fell by 7.94% to -$8.2 million in 2024, then tumbled by 160.41% to -$21.2 million in 2025, then surged by 147.93% to $10.2 million in 2026.
- Business Quant data shows JAGX's Operating Income at $10.2 million in Q1 2026, -$21.2 million in Q4 2025, and -$7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 10.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.18 Mn |
| Dec 31, 2025 | -21.24 Mn |
| Sep 30, 2025 | -7.24 Mn |
| Jun 30, 2025 | -8.01 Mn |
| Mar 31, 2025 | -9.42 Mn |
| Dec 31, 2024 | -8.16 Mn |
| Sep 30, 2024 | -7.26 Mn |
| Jun 30, 2024 | -7.20 Mn |
| Mar 31, 2024 | -8.22 Mn |
| Dec 31, 2023 | -7.56 Mn |
| Sep 30, 2023 | -8.79 Mn |
| Jun 30, 2023 | -8.10 Mn |
| Mar 31, 2023 | -9.85 Mn |
| Dec 31, 2022 | -6.29 Mn |
| Sep 30, 2022 | -9.90 Mn |
| Jun 30, 2022 | -6.48 Mn |
| Mar 31, 2022 | -11.75 Mn |
| Dec 31, 2021 | -10.82 Mn |
| Sep 30, 2021 | -9.53 Mn |
| Jun 30, 2021 | -11.58 Mn |